Biopreservation Market 2023 Report Predictions by Global Market Trends, Future Growth, Regional Overview and Forecast Outlook until 2030

 

Biopreservation Market Growth & Trends

The biopreservation market is projected to register a robust CAGR of around 15% during the forecast period, driven by the expanding applications of personalized medicine, cell-based therapies, and the increasing establishment of biobanks and tissue repositories worldwide. Rising R&D spending in biotechnology and life sciences is further supporting market expansion. However, factors such as high equipment costs and the stringent regulatory framework governing biospecimen storage may act as growth restraints.

Get Free Sample Report: https://meditechinsights.com/biopreservation-market/request-sample/

What is Biopreservation?

Biopreservation refers to the process of preserving biological materials such as cells, tissues, blood, and organs under controlled cryogenic conditions to maintain their structural and functional integrity. The technique uses cryoprotective agents (CPAs) to prevent ice crystal formation, thereby safeguarding cell viability during freezing and thawing cycles. This preservation approach plays a pivotal role in biobanking, regenerative medicine, and the long-term storage of biospecimens used in research and clinical applications.

Rising Demand for Regenerative and Stem Cell Therapies Boosts Market Growth

The growing focus on regenerative medicine and advanced cellular therapies—including stem cell treatments, gene editing, and tissue engineering—is a key catalyst for the biopreservation industry. These therapies depend on the ability to maintain biological samples in optimal condition over extended periods.
With the increasing use of stem cells to address chronic diseases such as diabetes, cardiovascular disorders, and Parkinson’s disease, demand for reliable preservation systems has surged. In addition, the growing number of clinical trials and biotech research initiatives has accelerated investments in cold chain infrastructure and standardized biobanking protocols.

For instance, in April 2024, Thermo Fisher Scientific launched its ENERGY STAR® certified TSX Universal Series ultra-low temperature (ULT) freezers, designed to deliver improved temperature control, faster recovery, and greater energy efficiency—supporting laboratories focused on both performance and sustainability.

Vitrification Gains Momentum for Enhanced Post-Thaw Viability

Recent innovations have reshaped the biopreservation landscape, particularly through the adoption of vitrification—a rapid freezing process that converts biological materials into a glass-like, solid state without ice crystal formation. This method employs high concentrations of cryoprotectants and ultra-rapid cooling, proving especially effective for sensitive samples such as oocytes, embryos, and stem cells, which are vulnerable to damage under conventional slow-freezing techniques.

Vitrification’s superior post-thaw survival rates and ability to preserve cell structure have expanded its use across organ transplantation, regenerative research, and fertility preservation. The technology’s precision and reproducibility make it increasingly indispensable in both clinical and research environments, reinforcing its role in advancing modern biopreservation practices.

Competitive Landscape

The global biopreservation market is characterized by strong competition, with participation from leading and emerging players including:
Azenta US, Inc.; Biomatrica, Inc. (Exact Sciences Corporation); BioLife Solutions; MVE Biological Solutions; Taylor-Wharton; Thermo Fisher Scientific, Inc.; LabVantage Solutions, Inc.; X-Therma Inc.; PrincetonCryo; Panasonic Healthcare Holdings Co., Ltd.; and Stirling Ultracold, among others.

Market leaders are actively pursuing product innovations, strategic partnerships, and geographical expansion to strengthen their global presence and meet the growing demand for efficient, sustainable biopreservation systems.

key Request a free sample copy or view report summary: https://meditechinsights.com/biopreservation-market/request-sample/

Table of content:

1.      Research Methodology​

o    Secondary Research​

o    Primary Research​

o    Market Estimation​

§  Bottom-Up Approach​

§  Top-Down Approach​

o    Market Forecasting​

2.      Executive Summary

o    Biopreservation Market Snapshot (2025-2030)​

o    Segment Overview​

o    Regional Snapshot​

o    Competitive Insights ​

  1. Global Biopreservation Market Size & Forecast (2023-2030), By Biospecimen, USD Million
    • Introduction​
    • Tissue
    • Organs
    • Stem cells
    • Others
  2. Global Biopreservation Market Size & Forecast (2023-2030), By Application, USD Million
    • Introduction​
    • Therapeutics
    • Research
  3. Global Biopreservation Market Size & Forecast (2023-2030), By End-user, USD Million
    • Introduction​
    • Biobanks
    • Hospitals
    • Gene Banks
    • Others

About Us:

At Medi-Tech Insights, we are a global healthcare consulting firm committed to delivering premium insights and strategic solutions to help our clients navigate the complex and evolving healthcare landscape.

Our team combines deep industry expertise with data-driven market intelligence to provide actionable insights that enable smarter decisions and sustainable success.

With a strong focus on innovation, quality, and impact, Medi-Tech Insights has become a trusted partner for leading healthcare investors and corporates across the globe.

Comments

Post a Comment

Popular posts from this blog

Cell Analysis Market projected to witness a growth rate of 10-11% by 2028

The Cell Analysis Market i s expected to witness a growth rate of 10-11% by 2028.   The market is witnessing robust growth, fueled by the expanding application of cell-based assays in drug discovery and the surge in cell-based research funding . The growing burden of chronic and lifestyle-related diseases —including cancer, cardiovascular disorders, autoimmune conditions, and neurological illnesses—has intensified the need for advanced analytical tools that support the development of effective therapies. Get Free Sample Report: https://meditechinsights.com/cell-analysis-market/request-sample/ Cell analysis has become an essential component of modern biomedical research, enabling scientists to evaluate key cellular attributes such as viability, proliferation, morphology, and cytotoxicity . These insights are crucial for understanding disease mechanisms, identifying potential drug targets, and validating therapeutic candidates. Technological advancements, such as high-content sc...
Read more

High-Performance Liquid Chromatography (HPLC) Market Analysis by Key Drivers, Top Players, Forecast, Growth Rate, Constraints, Future Trends, Events, And Challenges Until 2029

  High-Performance Liquid Chromatography (HPLC) Market Overview The global High-Performance Liquid Chromatography (HPLC) market is projected to register a steady growth rate of approximately 4–6% by 2029. This growth is largely driven by the increasing need for analytical techniques that deliver high precision, sensitivity, and efficiency. Factors such as rapid technological progress, rising R&D investments, and expanding application areas continue to strengthen the market outlook. Get Free Sample Report : https://meditechinsights.com/high-performance-liquid-chromatography-market/request-sample/ HPLC: The Cornerstone of Modern Analytical Science High-Performance Liquid Chromatography (HPLC) is a highly efficient analytical method used to separate, detect, and quantify components within complex mixtures. Based on chromatographic principles, HPLC involves passing a liquid sample through a stationary phase within a high-pressure column. Differences in molecular interacti...
Read more

Autoinjectors Market with Highest growth in the near future by leading key players

  The global autoinjectors market is on track to expand significantly, with an anticipated growth rate of 14–16% by 2028 . This upward trajectory is fueled by a combination of rising chronic and lifestyle-related health conditions, a growing patient preference for self-managed treatment, and rapid advancements in drug delivery technologies. Additionally, the increasing prevalence of biologics and biosimilars—many of which require routine injections—is further accelerating the demand for autoinjectors. Autoinjectors: Revolutionizing Self-Administered Therapy Autoinjectors are spring-powered medical devices engineered to deliver medications either subcutaneously or intramuscularly. These compact tools often incorporate pre-filled syringes or cartridges, enabling patients to administer drugs with minimal effort and high precision. By simplifying the injection process, autoinjectors help alleviate patient anxiety, ensure accurate dosing, and significantly improve adherence to trea...
Read more